Menú / Directrices y buenas prácticas ISPOR •   Alemania: Methods for Assessment of the Relation of Benefits to Costs in the German Statutory Health Care System - Version 2.0 (German version); Marzo 2009 •   “Analysis of differences and commonalities in pricing and reimbursement systems in Europe” A study funded by DG Enterprise and Industry of the European Commission. Final Report; Junio 2007 •   Australia: Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (Version 4.3); Diciembre 2008 •   Canadá: Guidelines for the economic evaluation of health technologies: Canada [3rd Edition]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2006 •   España: Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias. Madrid: Plan Nacional para el SNS del MSC. Servicio de Evaluación del Servicio Canario de la Salud; 2008 •   ISPOR Good Outcomes Research Practices & Issues. •   ISPOR Pharmacoeconomic Guidelines Around the World. •   UK: Guide to the methods of technology appraisal; Junio 2008